Line utilization in integrated document delivery method and apparatus
    51.
    发明授权
    Line utilization in integrated document delivery method and apparatus 有权
    集成文件传送方式和装置中的线路利用

    公开(公告)号:US07876468B2

    公开(公告)日:2011-01-25

    申请号:US12567656

    申请日:2009-09-25

    IPC分类号: G06F3/12

    摘要: A document delivery network server having a set of integrated functions including sending, receiving, routing and filing of FAXes and e-mails to other users which achieves numerous advantages over the prior art. The document delivery system is based on a client/server model having both analog and digital Fax line capabilities. The server side provides very highly integrated systems functionality based on industry standard, commercially available hardware and a mix of industry standard and proprietary software components including integrated FAX/modem modules, an embedded OS, embedded plug-and-play driver sets, embedded e-mail gateways, an embedded FAX archive, embedded back-up/restore, proprietary high efficiency line utilization and highly efficient load balancing.

    摘要翻译: 一种文档传送网络服务器,其具有一组集成功能,包括向其他用户发送,接收,路由和归档传真和电子邮件,这相对于现有技术实现了许多优点。 文档传送系统基于具有模拟和数字传真线路功能的客户端/服务器模型。 服务器端提供非常高度集成的系统功能,基于行业标准,市售硬件以及业界标准和专有软件组件的混合,包括集成的传真/调制解调器模块,嵌入式操作系统,嵌入式即插即用驱动程序集, 邮件网关,嵌入式FAX归档,嵌入式备份/恢复,专有的高效率线路利用率和高效负载平衡。

    PCSK9 polypeptides
    52.
    发明授权
    PCSK9 polypeptides 有权
    PCSK9多肽

    公开(公告)号:US07846706B2

    公开(公告)日:2010-12-07

    申请号:US12456798

    申请日:2009-06-23

    摘要: The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码PCSK9b和PCSK9c多肽的新型多核苷酸,其片段和同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型PCSK9b和PCSK9c多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    METHOD FOR SCOURING AND BLEACHING COTTON FABRIC WITH COMPOSITE ENZYME PREPARATION IN ONE BATH
    53.
    发明申请
    METHOD FOR SCOURING AND BLEACHING COTTON FABRIC WITH COMPOSITE ENZYME PREPARATION IN ONE BATH 审中-公开
    一次浴中复合酶制剂的洗涤和漂白棉织物的方法

    公开(公告)号:US20100192308A1

    公开(公告)日:2010-08-05

    申请号:US12667577

    申请日:2008-06-16

    IPC分类号: D06L3/14

    摘要: A method for scouring and bleaching cotton fabric with composite enzyme preparation in one bath is provided. The method relates to the application of composite alkaline enzyme preparation in scouring and bleaching processes of cotton fabric. The enzyme preparation for scouring and bleaching cotton fabric is compounded from cutinase, alkaline pectase, alkaline xylanase, alkaline cellulose, and carbohydrate oxidase. The method includes: scouring the cotton fabric by adding the composite enzyme preparation, glucose, oxidation bleaching stabilizer RB-3, penetrant JFC, and Triton X-100 in a treating bath at 55-70° C. and pH 8-10, and then bleaching the cotton fabric for 30 min by directly adding tetraacetyl ethylenediamine (TAED) in the scouring bath to activate hydrogen peroxide. After being treated by the method of the present invention, the cotton fabric has high impurity removal ratio, favorable wettability, and high whiteness. The present invention has the advantages of low power consumption, short process flow, and being environment friendly, and may be used to replace conventional chemical treatment process under the condition of concentrated alkali and high temperature.

    摘要翻译: 提供了在一个浴中用复合酶制剂冲洗和漂白棉织物的方法。 该方法涉及复合碱性酶制剂在棉织物的漂洗和漂白过程中的应用。 用于冲洗和漂白棉织物的酶制剂由角质酶,碱性果胶酶,碱性木聚糖酶,碱性纤维素和碳水化合物氧化酶组合。 该方法包括:通过在55-70℃和pH8-10的处理浴中加入复合酶制剂,葡萄糖,氧化漂白稳定剂RB-3,渗透剂JFC和Triton X-100来洗涤棉织物,以及 然后通过在洗涤浴中直接加入四乙酰乙二胺(TAED)来活化过氧化氢,使棉织物漂白30分钟。 在通过本发明的方法处理之后,棉织物具有高杂质去除率,良好的润湿性和高白度。 本发明具有功耗低,工艺流程短,环保的优点,可用于在浓碱和高温条件下代替常规化学处理工艺。

    Retention margin program verification
    56.
    发明授权
    Retention margin program verification 有权
    保留保证金计划验证

    公开(公告)号:US07616499B2

    公开(公告)日:2009-11-10

    申请号:US11617541

    申请日:2006-12-28

    IPC分类号: G11C11/34 G11C16/04 G11C16/06

    摘要: Data verification in a memory device using a portion of a data retention margin is provided. A bit count is read from the region to determine whether errors will result in the memory. A read in one or more retention margin portions is performed after the normal program verify sequence and if the number of bits in these regions is more than a pre-set the memory will fail verify status. A method of verifying data in a memory device includes the steps of: defining an retention margin between adjacent data thresholds; programming the memory device with data; determining whether bits are present in the data retention margin; and if the number of bits in the retention margin exceeds a threshold, generating an error.

    摘要翻译: 提供了使用部分数据保留余量的存储器件中的数据验证。 从区域读取位计数,以确定错误是否会导致内存。 在正常程序验证序列之后执行在一个或多个保留边缘部分中的读取,并且如果这些区域中的位数大于预设,则存储器将失败验证状态。 验证存储器件中的数据的方法包括以下步骤:定义相邻数据阈值之间的保留余量; 使用数据对存储设备进行编程; 确定位是否存在于数据保留余量中; 并且如果保留余量中的比特数超过阈值,则产生错误。

    Adiponectin receptor variant, AdipoR2v2
    57.
    发明授权
    Adiponectin receptor variant, AdipoR2v2 有权
    脂联素受体变体,AdipoR2v2

    公开(公告)号:US07598348B2

    公开(公告)日:2009-10-06

    申请号:US12148669

    申请日:2008-04-21

    IPC分类号: C07K14/72

    CPC分类号: C07K14/72

    摘要: The present invention provides novel polynucleotides encoding human AdipoR2v1 polypeptides, mouse AdipoR2v1 polypeptides, human AdipoR3 polypeptides, human AdipoR2v2 polypeptides, human AdipoR3v1 polypeptides, rat AdipoR1 polypeptides, rat AdipoR2 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel human AdipoR2v1 polypeptides, mouse AdipoR2v1 polypeptides, human AdipoR3 polypeptides, human AdipoR2v2 polypeptides, human AdipoR3v1 polypeptides, rat AdipoR1 polypeptides, rat AdipoR2 polypeptides, to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码人AdipoR2v1多肽,小鼠AdipoR2v1多肽,人AdipoR3多肽,人AdipoR2v2多肽,人AdipoR3v1多肽,大鼠AdipoR1多肽,大鼠AdipoR2多肽,其片段及其同源物的新型多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新的人AdipoR2v1多肽,小鼠AdipoR2v1多肽,人AdipoR3多肽,人AdipoR2v2多肽,人AdipoR3v1多肽,大鼠AdipoR1多肽,大鼠AdipoR2多肽应用于诊断,治疗和/或治疗的诊断和治疗方法。 预防与这些多肽相关的各种疾病和/或病症。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
    59.
    发明授权
    Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants 有权
    用于TRP通道家族成员的多肽,TRP-PLIK2和剪接变体

    公开(公告)号:US07541434B2

    公开(公告)日:2009-06-02

    申请号:US11726234

    申请日:2007-03-21

    CPC分类号: C07K14/705

    摘要: The present invention provides novel polynucleotides encoding TRP-PLIK2 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of TRP-PLIK2 polypeptides, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel TRP-PLIK2, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码TRP-PLIK2多肽的新型多核苷酸,其片段及其同源物。 本发明还提供分别编码TRP-PLIK2多肽,TRP-PLIK2b,TRP-PLIK2c和TRP-PLIK2d的变体和剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型TRP-PLIK2,TRP-PLIK2b,TRP-PLIK2c和TRP-PLIK2d多肽应用于诊断,治疗和/或预防与这些相关的各种疾病和/或病症的诊断和治疗方法 多肽。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。